Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study (Q36087887)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study |
scientific article |
Statements
1 reference
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study (English)
1 reference
George Wilding
1 reference
Alejandro D Ricart
1 reference
Anthony W Tolcher
1 reference
Glenn Liu
1 reference
Kyle Holen
1 reference
Garry Schwartz
1 reference
Mark Albertini
1 reference
Geoffrey Weiss
1 reference
Salim Yazji
1 reference
Chee Ng
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference